Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017:2017:3514796.
doi: 10.1155/2017/3514796. Epub 2017 Feb 23.

Bilateral Olecranon Tophaceous Gout Bursitis

Affiliations
Case Reports

Bilateral Olecranon Tophaceous Gout Bursitis

Güzelali Özdemir et al. Case Rep Med. 2017.

Abstract

In this case, we present a patient with the diagnosis of bilateral olecranon tophaceous gout. After the surgical treatment, there was no limitation of range of motion or wound problem at 6th month control.

PubMed Disclaimer

Conflict of interest statement

The authors declare they have no conflict of interests in publishing this case study.

Figures

Figure 1
Figure 1
Images of X-ray, right and left elbow: The direct preoperation radiographies showed no significant changes or calcification (9/5/16).
Figure 2
Figure 2
Preoperation right elbow MRI images, T1a and T2a sections, at site of the posterior bursa of 44 × 21 × 32 mm sized complicated tissue. No destruction of bone (9/5/16).
Figure 3
Figure 3
Posterior longitudinal approach of the left elbow.
Figure 4
Figure 4
The mass was enucleated and dissected. Preoperation photographs of the left elbow mass; before removal and after closure of the skin (16/5/16).
Figure 5
Figure 5
Two pieces of the specimens about 4.5 cm each, prepared and sent for pathologic examination.
Figure 6
Figure 6
Postoperative 17th day, patient reached full joint range of motion (2/6/16).

Similar articles

Cited by

References

    1. Monu J. U. V., Pope T. L., Jr. Gout: a clinical and radiologic review. Radiologic Clinics of North America. 2004;42(1):169–184. doi: 10.1016/s0033-8389(03)00158-1. - DOI - PubMed
    1. Luk A. J., Simkin P. A. Epidemiology of hyperuricemia and gout. American Journal of Managed Care. 2005;11(15):S435–S442. - PubMed
    1. Kasper I. R., Juriga M. D., Giurini J. M., Shmerling R. H. Treatment of tophaceous gout: when medication is not enough. Seminars in Arthritis & Rheumatism. 2016;45(6):669–674. doi: 10.1016/j.semarthrit.2016.01.005. - DOI - PubMed
    1. Girishkumar J., Mruthyunjaya, Rupakumar C. S. Bilateral olecranon bursitis—a rare clinical presentation of calcium pyrophosphate crystal deposition disease. Journal of Orthopaedic Case Reports. 2014;4(1):3–6. doi: 10.13107/jocr.2250-0685.137. - DOI - PMC - PubMed
    1. Falasca G. F. Metabolic diseases: gout. Clinics in Dermatology. 2006;24(6):498–508. doi: 10.1016/j.clindermatol.2006.07.015. - DOI - PubMed

Publication types

LinkOut - more resources